$7.04
-0.17-2.36%
Last update: Dec 15, 3:41 PM
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Comments
Loading...
Myriad Genetics Insider Trading Activity
MYGNNASDAQ
Myriad Genetics Insider Trading Activity | NASDAQ:MYGN | Benzinga
Track the latest Myriad Genetics insider trading activity. Stay informed on recent buys, sells, and market impact for Myriad Genetics stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Myriad Genetics Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for Myriad Genetics Inc
Shares Outstanding
93.214M
Insider Shares Owned
8.364M
Insider Percentage Owned
9.07%
Institutional Shares Held
45.201M
Institutional Percentage Held
48.5%
| Oct 11, 2024 | Paul J Diaz | PRESIDENT AND CEO | -15.00K | $22.93 | -$343.95K | SELL | -1.53% | 962.38K | Oct 11 | View |
| Sep 12, 2024 | Paul J Diaz | PRESIDENT AND CEO | -15.00K | $26.72 | -$400.80K | SELL | -1.51% | 977.38K | Sep 11 | View |
| Sep 12, 2024 | Dale Muzzey | CHIEF SCIENTIFIC OFFICER | -2.10K | $26.17 | -$54.96K | SELL | -1.91% | 108.01K | Sep 11 | View |
| Sep 09, 2024 | Heinrich Dreismann | DIRECTOR | -10.00K | $27.05 | -$270.52K | SELL | -7.60% | 121.65K | Sep 09 | View |
| Sep 04, 2024 | Colleen F Reitan | DIRECTOR | -46.01K | $27.95 | -$1.29M | SELL | -51.96% | 42.53K | Sep 03 | View |
| Aug 23, 2024 | Margaret Ancona | SVP, CHIEF STAFF | -11.54K | $27.82 | -$320.99K | SELL | -12.69% | 79.37K | Aug 21 | View |
| Aug 20, 2024 | Rashmi Kumar | DIRECTOR | -7.50K | $28.01 | -$210.07K | SELL | -8.83% | 77.39K | Aug 19 | View |
| Jun 04, 2024 | Daniel K Spiegelman | DIRECTOR | -7.58K | $22.04 | -$167.01K | SELL | -18.71% | 32.92K | Jun 03 - Jun 04 | View |
| May 15, 2024 | Paul J Diaz | PRESIDENT AND CEO | -227.84K | $25.14 | -$5.73M | SELL | -17.61% | 1.07M | May 13 - May 15 | View |
| May 15, 2024 | Lee Nisley Newcomer | DIRECTOR | -6.20K | $25.30 | -$156.86K | SELL | -8.51% | 66.65K | May 13 | View |
| Dec 05, 2023 | Richard Bryan Riggsbee | CHIEF FINANCIAL OFFICER | -30.00K | $19.09 | -$572.84K | SELL | -9.32% | 291.81K | Dec 01 | View |
| Nov 03, 2023 | Richard Bryan Riggsbee | CHIEF FINANCIAL OFFICER | -30.00K | $15.69 | -$470.62K | SELL | -8.53% | 321.81K | Nov 01 | View |
| Jun 02, 2023 | Daniel K Spiegelman | DIRECTOR | 6.51K | $23.01 | -$198.76K | GRANT | 19.17% | 40.49K | Jun 01 - Jun 02 | View |
| Mar 28, 2023 | Nicole Lambert | CHIEF OPERATING OFFICER | -6.43K | $23.48 | -$151.05K | SELL | -2.61% | 240.51K | Mar 27 | View |
| Mar 03, 2023 | Richard Bryan Riggsbee | CHIEF FINANCIAL OFFICER | -15.00K | $22.55 | -$338.25K | SELL | -4.25% | 337.88K | Mar 02 | View |
| Mar 03, 2023 | Nicole Lambert | CHIEF OPERATING OFFICER | -13.18K | $22.74 | -$299.82K | SELL | -5.77% | 215.22K | Mar 02 | View |
| Jan 23, 2023 | Richard Bryan Riggsbee | CHIEF FINANCIAL OFFICER | -9.40K | $20.04 | -$188.39K | SELL | -2.52% | 364.11K | Jan 20 | View |
| Jan 19, 2023 | Richard Bryan Riggsbee | CHIEF FINANCIAL OFFICER | -600.00 | $20.01 | -$12.01K | SELL | -0.16% | 373.51K | Jan 18 | View |
| Dec 28, 2022 | Richard Bryan Riggsbee | CHIEF FINANCIAL OFFICER | -20.00K | $15.15 | -$302.99K | SELL | -5.07% | 374.11K | Dec 27 | View |
| Jun 06, 2022 | Daniel K Spiegelman | DIRECTOR | -6.42K | $19.25 | -$123.67K | SELL | -15.90% | 33.98K | Jun 06 | View |
| Mar 01, 2022 | Jayne B Hart | CHIEF PEOPLE OFFICER | 0.00 | $24.49 | -$10.71K | SELL-OPTIONS | 0.00% | 165.88K | Feb 28 | View |
| Oct 04, 2021 | Nicole Lambert | SEE REMARKS | -1.42K | $31.57 | -$44.83K | SELL | -0.80% | 176.65K | Oct 01 | View |
| Sep 27, 2021 | Nicole Lambert | SEE REMARKS | -14.85K | $33.17 | -$492.54K | SELL | -7.70% | 178.07K | Sep 25 - Sep 27 | View |
| Sep 27, 2021 | Jerry S Lanchbury | CHIEF SCIENTIFIC OFFICER | -13.58K | $33.34 | -$452.70K | SELL | -4.70% | 275.13K | Sep 23 - Sep 26 | View |
| Sep 21, 2021 | Jayne B Hart | CHIEF PEOPLE OFFICER | 9.55K | $30.10 | -$234.55K | SELL-OPTIONS | 11.93% | 89.62K | Sep 17 | View |
| Aug 30, 2021 | Nicole Lambert | SEE REMARKS | -945.00 | $34.50 | -$32.60K | SELL | -0.74% | 127.05K | Aug 27 | View |
| Aug 25, 2021 | Jerry S Lanchbury | CHIEF SCIENTIFIC OFFICER | 0.00 | $31.20 | -$660.00K | SELL-OPTIONS | 0.00% | 232.55K | Aug 23 - Aug 24 | View |
| Aug 06, 2021 | Jerry S Lanchbury | CHIEF SCIENTIFIC OFFICER | 0.00 | $31.32 | -$239.96K | SELL-OPTIONS | 0.00% | 232.55K | Aug 05 | View |
| Aug 06, 2021 | S. Louise Phanstiel | DIRECTOR | 12.12K | $29.19 | -$277.34K | SELL-OPTIONS | 12.06% | 112.65K | Aug 05 | View |
| Aug 05, 2021 | Richard Bryan Riggsbee | CHIEF FINANCIAL OFFICER | -14.98K | $35.14 | -$526.48K | SELL | -4.41% | 324.94K | Aug 03 | View |
| Aug 05, 2021 | Jerry S Lanchbury | CHIEF SCIENTIFIC OFFICER | 0.00 | $30.33 | -$869.05K | SELL-OPTIONS | 0.00% | 232.55K | Aug 03 - Aug 04 | View |
| Aug 05, 2021 | Dennis Langer | DIRECTOR | 0.00 | $30.07 | -$280.80K | SELL-OPTIONS | 0.00% | 89.53K | Aug 03 | View |
| Jul 14, 2021 | Jerry S Lanchbury | CHIEF SCIENTIFIC OFFICER | 0.00 | $30.06 | -$666.89K | SELL-OPTIONS | 0.00% | 232.55K | Jul 12 - Jul 13 | View |
| Jul 12, 2021 | Jerry S Lanchbury | CHIEF SCIENTIFIC OFFICER | 0.00 | $28.31 | -$430.73K | SELL-OPTIONS | 0.00% | 232.55K | Jul 09 | View |
| Jul 08, 2021 | Jerry S Lanchbury | CHIEF SCIENTIFIC OFFICER | 0.00 | $29.38 | -$186.82K | SELL-OPTIONS | 0.00% | 232.55K | Jul 07 | View |
| Jun 30, 2021 | Jerry S Lanchbury | CHIEF SCIENTIFIC OFFICER | 0.00 | $28.95 | -$46.81K | SELL-OPTIONS | 0.00% | 232.55K | Jun 28 | View |
| Jun 28, 2021 | Jerry S Lanchbury | CHIEF SCIENTIFIC OFFICER | -33.37K | $25.71 | -$1.69M | SELL | -12.55% | 232.55K | Jun 25 | View |
| Jun 17, 2021 | Daniel K Spiegelman | DIRECTOR | -3.14K | $30.52 | -$95.79K | SELL | -11.95% | 23.13K | Jun 17 | View |
| Jun 01, 2021 | Daniel K Spiegelman | DIRECTOR | -7.14K | $28.99 | -$207.02K | SELL | -34.73% | 13.42K | May 28 | View |
| May 05, 2021 | Jerry S Lanchbury | CHIEF SCIENTIFIC OFFICER | 0.00 | $25.72 | -$242.01K | SELL-OPTIONS | 0.00% | 265.92K | May 04 | View |
| Apr 28, 2021 | Jerry S Lanchbury | CHIEF SCIENTIFIC OFFICER | 0.00 | $25.47 | -$480.00K | SELL-OPTIONS | 0.00% | 265.92K | Apr 27 | View |
| Apr 20, 2021 | Nicole Lambert | SEE REMARKS | -6.65K | $27.01 | -$179.59K | SELL | -4.90% | 129.12K | Apr 19 | View |
| Mar 30, 2021 | Jayne B Hart | CHIEF PEOPLE OFFICER | 0.00 | $26.14 | -$448.14K | SELL-OPTIONS | 0.00% | 80.13K | Mar 29 | View |
| Feb 17, 2021 | Jeremy S. Lanchbury | CHIEF SCIENTIFIC OFFICER | 0.00 | $23.86 | -$937.05K | SELL-OPTIONS | 0.00% | 246.57K | Feb 16 | View |
| Jan 11, 2021 | Paul Parkinson | EVP STRATEGY AND INNOVATION | -11.82K | $25.00 | -$295.60K | SELL | -13.35% | 76.75K | Jan 08 | View |
| Nov 12, 2020 | Louise S. Phanstiel | — | 15.00K | $16.62 | $249.34K | PURCHASE | 26.41% | 71.79K | Nov 11 | View |
| Sep 16, 2020 | Alexander Ford | — | -2.80K | $13.78 | -$38.63K | SELL | -1.82% | 151.16K | Sep 15 | View |
| Feb 12, 2020 | Nicole Lambert | — | -4.35K | $19.73 | -$85.91K | SELL | -6.86% | 59.15K | Feb 12 | View |
| Feb 07, 2020 | Alexander Ford | — | -7.27K | $30.00 | -$218.19K | SELL | -4.86% | 142.44K | Feb 05 | View |
| Dec 16, 2019 | Walter Gilbert | DIRECTOR | 5.86K | $25.60 | $150.00K | BUY | 12.14% | 54.15K | Dec 13 | View |
| Nov 07, 2019 | John T Henderson | DIRECTOR | 7.00K | $23.46 | $164.22K | BUY | ∞ | 2.05K | Nov 07 | View |
| Aug 02, 2019 | Mark C. Capone | PRESIDENT & C.E.O. | 0.00 | $35.19 | -$2.41M | SELL-OPTIONS | 0.00% | 440.83K | Aug 01 | View |
| Aug 02, 2019 | Gary A King | EXEC. VP INTERNATIONAL OPS | 0.00 | $33.61 | -$1.19M | SELL-OPTIONS | 0.00% | 134.87K | Aug 01 | View |
| Aug 02, 2019 | Bernard Tobin | PRESIDENT CRESCENDO BIOSCIENCE | -11.71K | $40.00 | -$468.48K | SELL | -7.42% | 146.04K | Aug 01 | View |
| Aug 02, 2019 | Richard Bryan Riggsbee | CHIEF FINANCIAL OFFICER | -25.00K | $41.50 | -$1.04M | SELL | -17.17% | 120.57K | Aug 01 | View |
| Mar 12, 2019 | Ralph McDade | PRESIDENT MYRIAD RBM, INC. | -1.98K | $31.00 | -$61.23K | SELL | -1.59% | 122.60K | Mar 12 | View |
| Jul 13, 2018 | Jeremy S Lanchbury | CHIEF SCIENTIFIC OFFICER | 0.00 | $36.84 | -$650.04K | SELL-OPTIONS | 0.00% | 138.81K | Jul 11 | View |
| Jul 13, 2018 | John T Henderson | DIRECTOR | 0.00 | $33.22 | -$530.09K | SELL-OPTIONS | 0.00% | 50.04K | Jul 11 | View |
| Jul 13, 2018 | Richard Marsch | E.V.P., GENERAL COUNSEL | -7.62K | $32.99 | -$1.40M | SELL | -6.14% | 116.57K | Jul 11 | View |
| Jul 13, 2018 | Mark C Capone | PRESIDENT & C.E.O. | 0.00 | $35.56 | -$870.40K | SELL-OPTIONS | 0.00% | 332.18K | Jul 11 | View |
| Jun 19, 2018 | JERRY LANCHBURY | CHIEF SCIENTIFIC OFFICER | 0.00 | $35.12 | -$600.00K | SELL-OPTIONS | 0.00% | 138.81K | Jun 18 | View |
| Jun 19, 2018 | Richard Marsh | E.V.P., GENERAL COUNSEL | 0.00 | $35.17 | -$318.78K | SELL-OPTIONS | 0.00% | 124.20K | Jun 18 | View |
| Jun 08, 2018 | Dennis Langer | DIRECTOR | 0.00 | $30.32 | -$367.94K | SELL-OPTIONS | 0.00% | 39.74K | Jun 06 - Jun 08 | View |
| Jun 07, 2018 | Walter Gilbert | DIRECTOR | 0.00 | $32.04 | -$458.89K | SELL-OPTIONS | 0.00% | 27.24K | Jun 05 - Jun 06 | View |
| Jun 05, 2018 | Dennis Langer | DIRECTOR | 0.00 | $31.55 | -$769.33K | SELL-OPTIONS | 0.00% | 39.74K | Jun 01 - Jun 05 | View |
| Jun 01, 2018 | Mark C Capone | PRESIDENT & C.E.O. | 0.00 | $30.46 | -$1.36M | SELL-OPTIONS | 0.00% | 332.18K | May 30 | View |
| Jun 01, 2018 | Richard Marsh | E.V.P., GENERAL COUNSEL | 0.00 | $34.17 | -$253.84K | SELL-OPTIONS | 0.00% | 123.77K | May 30 | View |
| Jun 01, 2018 | Dennis Langer | DIRECTOR | 0.00 | $31.16 | -$135.34K | SELL-OPTIONS | 0.00% | 39.74K | May 30 | View |
| May 21, 2018 | Dennis Langer | DIRECTOR | 0.00 | $30.14 | -$115.10K | SELL-OPTIONS | 0.00% | 39.74K | May 21 | View |
| Jan 22, 2018 | Gary A King | EXEC. VP INTERNATIONAL OPS | 0.00 | $29.48 | -$702.48K | SELL-OPTIONS | 0.00% | 121.97K | Jan 22 | View |
| Jan 22, 2018 | Richard M Marsh | E.V.P., GENERAL COUNSEL | 3.77K | $35.02 | -$281.47K | SELL-OPTIONS | 3.15% | 123.77K | Jan 22 | View |
| Jan 19, 2018 | Richard M Marsh | E.V.P., GENERAL COUNSEL | 0.00 | $34.19 | -$325.20K | SELL-OPTIONS | 0.00% | 119.99K | Jan 18 | View |
| Jan 19, 2018 | Gary A King | EXEC. VP INTERNATIONAL OPS | 0.00 | $26.50 | -$72.51K | SELL-OPTIONS | 0.00% | 121.97K | Jan 18 | View |
| Jan 16, 2018 | Richard M Marsh | E.V.P., GENERAL COUNSEL | -18.26K | $36.25 | -$498.76K | SELL | -13.21% | 119.99K | Oct 04 - Jan 12 | View |
| Dec 15, 2017 | Walter Gilbert | DIRECTOR | -7.50K | $33.19 | -$248.92K | SELL | -21.59% | 27.24K | Dec 14 | View |
| Dec 12, 2017 | Heinrich Dreismann | DIRECTOR | -6.00K | $33.50 | -$201.00K | SELL | -15.10% | 33.74K | Dec 11 | View |
| Nov 14, 2017 | Alexander Ford | PRESIDENT, MGL | -3.03K | $31.64 | -$95.90K | SELL | -3.80% | 76.77K | Nov 13 | View |
| Sep 05, 2017 | John T Henderson | DIRECTOR | 0.00 | $23.38 | -$415.24K | SELL-OPTIONS | 0.00% | 42.82K | Sep 01 | View |
| Feb 23, 2017 | John T Henderson | DIRECTOR | 6.00K | $18.66 | $111.93K | BUY | 16.29% | 42.82K | Feb 22 - Feb 23 | View |
| Sep 13, 2016 | John T Henderson | DIRECTOR | 0.00 | $15.55 | -$296.82K | SELL-OPTIONS | 0.00% | 21.80K | Sep 09 - Sep 12 | View |
| Aug 19, 2016 | Mark Capone | PRESIDENT & C.E.O. | 10.00K | $21.24 | $212.40K | BUY | 7.35% | 146.03K | Aug 19 | View |
| Aug 15, 2016 | Ralph McDade | PRESIDENT MYRIAD RBM, INC. | 1.00K | $21.49 | $21.49K | BUY | 1.79% | 56.72K | Aug 12 | View |
| Jun 22, 2016 | Alexander Ford | PRESIDENT, MGL | -2.19K | $24.68 | -$271.29K | SELL | -6.31% | 32.48K | Jun 21 | View |
| Apr 08, 2016 | Gary A King | EXEC. VP INTERNATIONAL OPS | 0.00 | $28.52 | -$315.45K | SELL-OPTIONS | 0.00% | 80.64K | Apr 06 | View |
| Apr 05, 2016 | Gary A King | EXEC. VP INTERNATIONAL OPS | 0.00 | $26.50 | -$348.60K | SELL-OPTIONS | 0.00% | 80.64K | Apr 01 | View |
| Dec 14, 2015 | Walter Gilbert | DIRECTOR | -5.00K | $42.23 | -$211.15K | SELL | -28.57% | 12.50K | Dec 11 | View |
| Dec 09, 2015 | Louise Phanstiel | DIRECTOR | -5.00K | $44.00 | -$220.00K | SELL | -27.03% | 13.50K | Dec 08 | View |
| Nov 05, 2015 | Heinrich Dreismann | DIRECTOR | 0.00 | $35.47 | -$1.08M | SELL-OPTIONS | 0.00% | 10.00K | Nov 05 | View |
| Nov 05, 2015 | Richard M Marsh | E.V.P., GENERAL COUNSEL | -4.37K | $33.72 | -$754.95K | SELL | -6.00% | 68.38K | Oct 21 - Nov 04 | View |
| Oct 28, 2015 | Gary King | EXEC. VP INTERNATIONAL OPS | 0.00 | $33.40 | -$188.40K | SELL-OPTIONS | 0.00% | 80.57K | Oct 28 | View |
| Oct 28, 2015 | Jerry Lanchbury | CHIEF SCIENTIFIC OFFICER | 0.00 | $32.39 | -$964.71K | SELL-OPTIONS | 0.00% | 70.74K | Oct 28 | View |
| Oct 27, 2015 | Jerry Lanchbury | CHIEF SCIENTIFIC OFFICER | 0.00 | $29.82 | -$593.62K | SELL-OPTIONS | 0.00% | 70.74K | Oct 23 - Oct 27 | View |
| Sep 17, 2015 | Jerry Lanchbury | CHIEF SCIENTIFIC OFFICER | -6.90K | $28.41 | -$1.68M | SELL | -8.88% | 70.74K | Sep 15 - Sep 17 | View |
| Sep 17, 2015 | Richard Marsh | E.V.P., GENERAL COUNSEL | -6.68K | $32.10 | -$917.85K | SELL | -9.00% | 67.54K | Sep 16 - Sep 17 | View |
| Sep 16, 2015 | Gary King | EXEC. VP INTERNATIONAL OPS | 0.00 | $29.44 | -$290.37K | SELL-OPTIONS | 0.00% | 51.47K | Sep 14 | View |
| Sep 08, 2015 | Gary King | EXEC. VP INTERNATIONAL OPS | 0.00 | $29.44 | -$507.23K | SELL-OPTIONS | 0.00% | 51.47K | Sep 03 | View |
| Sep 02, 2015 | Gary King | EXEC. VP INTERNATIONAL OPS | 0.00 | $28.11 | -$303.45K | SELL-OPTIONS | 0.00% | 51.47K | Sep 02 | View |
| Aug 31, 2015 | Gary King | EXEC. VP INTERNATIONAL OPS | 0.00 | $25.30 | -$625.50K | SELL-OPTIONS | 0.00% | 51.47K | Aug 28 | View |
| Nov 05, 2014 | Gary A King | EXEC. VP INTERNATIONAL OPS | 0.00 | $29.71 | -$134.51K | SELL-OPTIONS | 0.00% | 50.70K | Nov 03 | View |
| Oct 02, 2014 | James S Evans | CHIEF FINANCIAL OFFICER | 0.00 | $23.86 | -$661.28K | SELL-OPTIONS | 0.00% | 48.13K | Sep 30 | View |
| Sep 26, 2014 | James S Evans | CHIEF FINANCIAL OFFICER | 0.00 | $34.05 | -$69.09K | SELL-OPTIONS | 0.00% | 48.13K | Sep 24 | View |
| Sep 23, 2014 | James S Evans | CHIEF FINANCIAL OFFICER | 0.00 | $31.65 | -$1.38M | SELL-OPTIONS | 0.00% | 48.13K | Sep 19 - Sep 23 | View |
| Jul 15, 2014 | Peter D Meldrum | PRESIDENT & C.E.O. | -8.54K | $24.27 | -$731.04K | SELL | -56.64% | 6.54K | Apr 04 - Jul 14 | View |
| Jul 15, 2014 | Jerry S Lanchbury | CHIEF SCIENTIFIC OFFICER | 0.00 | $28.96 | -$435.88K | SELL-OPTIONS | 0.00% | 14.55K | Jul 14 | View |
| Jun 06, 2014 | John T Henderson | DIRECTOR | 0.00 | $21.65 | -$140.51K | SELL-OPTIONS | 0.00% | 4.30K | Jun 05 | View |
| May 09, 2014 | Ronald S Rogers | EXEC VP CORP COMMUNICATIONS | 0.00 | $30.56 | -$136.13K | SELL-OPTIONS | 0.00% | 0.00 | May 09 | View |
| May 01, 2014 | Richard M Marsh | E.V.P., GENERAL COUNSEL | 0.00 | $27.54 | -$855.60K | SELL-OPTIONS | 0.00% | 18.29K | Apr 30 | View |
| Apr 25, 2014 | Richard M Marsh | E.V.P., GENERAL COUNSEL | 0.00 | $28.93 | -$685.16K | SELL-OPTIONS | 0.00% | 18.29K | Apr 23 | View |
| Apr 17, 2014 | Richard Marsh | E.V.P., GENERAL COUNSEL | -3.21K | $28.93 | -$619.24K | SELL | -14.93% | 18.29K | Apr 02 - Apr 16 | View |
| Apr 07, 2014 | Jayne B Hart | EXECUTIVE VP HUMAN RESOURCES | 0.00 | $32.15 | -$1.38M | SELL-OPTIONS | 0.00% | 930.00 | Apr 07 | View |
| Apr 04, 2014 | Jerry S Lanchbury | CHIEF SCIENTIFIC OFFICER | -3.00K | $27.28 | -$2.35M | SELL | -17.09% | 14.55K | Apr 02 | View |
| Apr 04, 2014 | James S Evans | CHIEF FINANCIAL OFFICER | 0.00 | $35.17 | -$772.80K | SELL-OPTIONS | 0.00% | 47.61K | Apr 02 | View |
| Apr 04, 2014 | Peter D Meldrum | PRESIDENT & C.E.O. | -11.00K | $34.84 | -$519.75K | SELL | -42.17% | 15.08K | Feb 24 - Apr 02 | View |
| Mar 20, 2014 | Peter D Meldrum | PRESIDENT & C.E.O. | 0.00 | $33.56 | -$378.40K | SELL-OPTIONS | 0.00% | 26.08K | Mar 19 | View |
| Mar 19, 2014 | Peter D Meldrum | PRESIDENT & C.E.O. | -29.57K | $32.64 | -$276.71K | SELL | -53.13% | 26.08K | Feb 12 - Mar 17 | View |
| Mar 13, 2014 | Richard M Marsh | E.V.P., GENERAL COUNSEL | 0.00 | $21.70 | -$1.27M | SELL-OPTIONS | 0.00% | 17.16K | Mar 12 | View |
| Mar 11, 2014 | John T Henderson | DIRECTOR | 0.00 | $22.73 | -$605.20K | SELL-OPTIONS | 0.00% | 4.30K | Mar 07 | View |
| Mar 07, 2014 | John T Henderson | DIRECTOR | 0.00 | $22.59 | -$149.94K | SELL-OPTIONS | 0.00% | 4.30K | Mar 05 | View |
| Feb 26, 2014 | Walter Gilbert | DIRECTOR | 0.00 | $30.99 | -$395.32K | SELL-OPTIONS | 0.00% | 0.00 | Feb 26 | View |
| Feb 25, 2014 | Mark C. Capone | PRESIDENT, MGL | 0.00 | $28.41 | -$1.79M | SELL-OPTIONS | 0.00% | 48.27K | Feb 25 | View |
| Feb 24, 2014 | Gary A King | EXEC. VP INTERNATIONAL OPS | 0.00 | $28.00 | -$400.00K | SELL-OPTIONS | 0.00% | 2.95K | Feb 24 | View |
| Feb 20, 2014 | Robert Gardner Harrison | CHIEF INFORMATION OFFICER | 0.00 | $24.74 | -$403.08K | SELL-OPTIONS | 0.00% | 324.00 | Feb 20 | View |
| Feb 20, 2014 | James S Evans | CHIEF FINANCIAL OFFICER | 0.00 | $21.64 | -$862.27K | SELL-OPTIONS | 0.00% | 47.61K | Feb 20 | View |
| Feb 20, 2014 | Richard M Marsh | E.V.P., GENERAL COUNSEL | 0.00 | $24.00 | -$743.24K | SELL-OPTIONS | 0.00% | 17.16K | Feb 19 | View |
| Feb 20, 2014 | Jerry S Lanchbury | CHIEF SCIENTIFIC OFFICER | 0.00 | $23.52 | -$754.00K | SELL-OPTIONS | 0.00% | 17.55K | Feb 18 | View |
| Feb 20, 2014 | Walter Gilbert | DIRECTOR | 0.00 | $27.98 | -$780.12K | SELL-OPTIONS | 0.00% | 0.00 | Feb 19 | View |
| Feb 20, 2014 | Heinrich Dreismann | DIRECTOR | 0.00 | $28.14 | -$411.30K | SELL-OPTIONS | 0.00% | 0.00 | Feb 18 | View |
| Feb 20, 2014 | Gary A King | EXEC. VP INTERNATIONAL OPS | 0.00 | $24.81 | -$496.55K | SELL-OPTIONS | 0.00% | 2.95K | Feb 18 | View |
| Feb 14, 2014 | Richard M Marsh | E.V.P., GENERAL COUNSEL | -4.20K | $19.66 | -$496.32K | SELL | -19.64% | 17.16K | Feb 07 - Feb 14 | View |
| Feb 12, 2014 | Robert Gardner Harrison | CHIEF INFORMATION OFFICER | -3.20K | $19.24 | -$340.11K | SELL | -90.81% | 324.00 | Feb 12 | View |
| Feb 10, 2014 | Mark C. Capone | PRESIDENT, MGL | 0.00 | $24.82 | -$1.27M | SELL-OPTIONS | 0.00% | 48.27K | Feb 10 | View |
| Feb 10, 2014 | James S Evans | CHIEF FINANCIAL OFFICER | 0.00 | $20.43 | -$882.78K | SELL-OPTIONS | 0.00% | 47.61K | Feb 07 | View |
| Feb 05, 2014 | Peter D Meldrum | PRESIDENT & C.E.O. | 0.00 | $19.55 | -$2.86M | SELL-OPTIONS | 0.00% | 55.66K | Feb 05 | View |
| Nov 08, 2013 | James S Evans | CHIEF FINANCIAL OFFICER | 0.00 | $16.25 | -$165.48K | SELL-OPTIONS | 0.00% | 47.18K | Nov 08 | View |
| Nov 08, 2013 | Peter D Meldrum | PRESIDENT & C.E.O. | -30.50K | $16.22 | -$653.83K | SELL | -35.40% | 55.66K | Nov 06 - Nov 08 | View |
| Jun 14, 2013 | Robert Gardner Harrison | CHIEF INFORMATION OFFICER | 0.00 | $27.00 | -$577.56K | SELL-OPTIONS | 0.00% | 3.10K | Jun 13 | View |
| May 17, 2013 | Mark C. Capone | PRESIDENT, MGL | 0.00 | $25.45 | -$1.24M | SELL-OPTIONS | 0.00% | 48.27K | May 16 | View |
| May 14, 2013 | Peter D Meldrum | PRESIDENT & C.E.O. | 0.00 | $20.91 | -$392.70K | SELL-OPTIONS | 0.00% | 85.31K | May 14 | View |
| May 10, 2013 | Peter D Meldrum | PRESIDENT & C.E.O. | 0.00 | $19.90 | -$1.84M | SELL-OPTIONS | 0.00% | 85.31K | May 08 - May 10 | View |
| May 10, 2013 | Richard M Marsh | E.V.P., GENERAL COUNSEL | -4.00K | $22.59 | -$1.00M | SELL | -16.32% | 20.52K | May 09 - May 10 | View |
| May 10, 2013 | Heinrich Dreismann | DIRECTOR | 0.00 | $24.61 | -$393.33K | SELL-OPTIONS | 0.00% | 0.00 | May 10 | View |
| Dec 11, 2012 | John Henderson | DIRECTOR | 0.00 | $17.18 | -$838.29K | SELL-OPTIONS | 0.00% | 4.30K | Dec 10 | View |
| Dec 04, 2012 | Jerry S Lanchbury | CHIEF SCIENTIFIC OFFICER | 0.00 | $17.91 | -$371.08K | SELL-OPTIONS | 0.00% | 17.73K | Dec 03 | View |
| Dec 04, 2012 | Robert Gardner Harrison | CHIEF INFORMATION OFFICER | -4.35K | $29.95 | -$104.22K | SELL | -65.34% | 2.31K | Nov 28 - Nov 30 | View |
| Dec 03, 2012 | Dennis Langer | DIRECTOR | 0.00 | $23.86 | -$841.87K | SELL-OPTIONS | 0.00% | 0.00 | Nov 29 - Nov 30 | View |
| Nov 21, 2012 | Peter D Meldrum | PRESIDENT & C.E.O. | 0.00 | $18.24 | -$494.07K | SELL-OPTIONS | 0.00% | 84.22K | Nov 19 | View |
| Nov 21, 2012 | Jerry S Lanchbury | CHIEF SCIENTIFIC OFFICER | 0.00 | $20.63 | -$976.71K | SELL-OPTIONS | 0.00% | 17.73K | Nov 19 | View |
| Nov 21, 2012 | Mark C. Capone | PRESIDENT, MGL | 0.00 | $23.22 | -$507.48K | SELL-OPTIONS | 0.00% | 48.27K | Nov 20 - Nov 21 | View |
| Nov 13, 2012 | Mark Capone | PRESIDENT, MGL | 0.00 | $21.60 | -$1.03M | SELL-OPTIONS | 0.00% | 48.27K | Nov 12 | View |
| Nov 13, 2012 | Peter Meldrum | PRESIDENT & C.E.O. | 0.00 | $17.85 | -$1.20M | SELL-OPTIONS | 0.00% | 84.22K | Nov 09 - Nov 12 | View |
| Nov 08, 2012 | Peter D Meldrum | PRESIDENT & C.E.O. | -68.00K | $17.80 | -$430.06K | SELL | -44.67% | 84.22K | Nov 06 - Nov 08 | View |
| Nov 08, 2012 | Jerry S Lanchbury | CHIEF SCIENTIFIC OFFICER | 0.00 | $19.12 | -$675.40K | SELL-OPTIONS | 0.00% | 17.73K | Nov 06 | View |
| Nov 08, 2012 | Richard Marsh | E.V.P., GENERAL COUNSEL | 0.00 | $18.61 | -$1.31M | SELL-OPTIONS | 0.00% | 24.03K | Nov 06 | View |
| Nov 08, 2012 | Robert Gardner Harrison | CHIEF INFORMATION OFFICER | 0.00 | $21.98 | -$620.53K | SELL-OPTIONS | 0.00% | 6.66K | Nov 06 | View |
| Nov 08, 2012 | Mark C. Capone | PRESIDENT, MGL | -1.00K | $20.46 | -$447.66K | SELL | -2.03% | 48.27K | Oct 03 - Nov 06 | View |
| Oct 09, 2012 | Jerry Lanchbury | CHIEF SCIENTIFIC OFFICER | 0.00 | $18.16 | -$80.65K | SELL-OPTIONS | 0.00% | 17.73K | Oct 04 | View |
| Oct 04, 2012 | Jerry S Lanchbury | CHIEF SCIENTIFIC OFFICER | 0.00 | $18.16 | -$62.04K | SELL-OPTIONS | 0.00% | 17.73K | Oct 03 | View |
| Oct 03, 2012 | James S Evans | CHIEF FINANCIAL OFFICER | 0.00 | $16.98 | -$776.04K | SELL-OPTIONS | 0.00% | 46.77K | Oct 02 | View |
| Sep 28, 2012 | James S Evans | CHIEF FINANCIAL OFFICER | 0.00 | $15.71 | -$591.85K | SELL-OPTIONS | 0.00% | 46.77K | Sep 28 | View |
| Sep 19, 2012 | Jerry S Lanchbury | CHIEF SCIENTIFIC OFFICER | -5.00K | $28.00 | -$140.00K | SELL | -21.99% | 17.73K | Sep 17 | View |
| Sep 14, 2012 | Peter D Meldrum | PRESIDENT & C.E.O. | 0.00 | $16.80 | -$432.01K | SELL-OPTIONS | 0.00% | 152.22K | Sep 14 | View |
| Sep 14, 2012 | James S Evans | CHIEF FINANCIAL OFFICER | 0.00 | $15.45 | -$128.01K | SELL-OPTIONS | 0.00% | 46.77K | Sep 13 | View |
| Sep 12, 2012 | Peter D Meldrum | PRESIDENT & C.E.O. | -34.00K | $16.46 | -$418.50K | SELL | -18.26% | 152.22K | Aug 20 - Sep 11 | View |
| Sep 12, 2012 | Mark C. Capone | PRESIDENT, MGL | 0.00 | $17.97 | -$357.52K | SELL-OPTIONS | 0.00% | 49.27K | Sep 10 | View |
| Sep 12, 2012 | Richard M Marsh | E.V.P., GENERAL COUNSEL | 0.00 | $17.41 | -$370.19K | SELL-OPTIONS | 0.00% | 15.85K | Sep 10 - Sep 11 | View |
| Sep 12, 2012 | James S Evans | CHIEF FINANCIAL OFFICER | 0.00 | $15.40 | -$568.73K | SELL-OPTIONS | 0.00% | 46.77K | Sep 10 - Sep 12 | View |
| Aug 21, 2012 | Walter Gilbert | DIRECTOR | 0.00 | $19.51 | -$777.41K | SELL-OPTIONS | 0.00% | 0.00 | Aug 20 - Aug 21 | View |
| Jul 18, 2012 | James S Evans | CHIEF FINANCIAL OFFICER | 0.00 | $17.35 | -$266.93K | SELL-OPTIONS | 0.00% | 46.77K | Jul 18 | View |
| Jul 13, 2012 | Peter D Meldrum | PRESIDENT & C.E.O. | 0.00 | $17.29 | -$25.45K | SELL-OPTIONS | 0.00% | 180.90K | Jul 13 | View |
| Jul 11, 2012 | Peter D Meldrum | PRESIDENT & C.E.O. | 0.00 | $17.20 | -$486.09K | SELL-OPTIONS | 0.00% | 180.90K | Jul 09 - Jul 10 | View |
| May 04, 2012 | Mark C. Capone | PRESIDENT, MGL | 0.00 | $17.99 | -$76.68K | SELL-OPTIONS | 0.00% | 49.27K | May 02 | View |
| May 04, 2012 | Richard M Marsh | E.V.P., GENERAL COUNSEL | 0.00 | $17.41 | -$13.43K | SELL-OPTIONS | 0.00% | 15.20K | May 02 | View |
| Apr 27, 2012 | Peter D Meldrum | PRESIDENT & C.E.O. | 0.00 | $15.35 | -$852.24K | SELL-OPTIONS | 0.00% | 180.90K | Apr 26 - Apr 27 | View |
| Apr 27, 2012 | Richard M Marsh | E.V.P., GENERAL COUNSEL | 0.00 | $16.92 | -$364.17K | SELL-OPTIONS | 0.00% | 15.20K | Apr 26 | View |
| Apr 24, 2012 | Peter D Meldrum | PRESIDENT & C.E.O. | 0.00 | $14.93 | -$839.21K | SELL-OPTIONS | 0.00% | 180.90K | Apr 20 | View |
| Mar 16, 2012 | Peter D Meldrum | PRESIDENT & C.E.O. | 0.00 | $16.81 | -$162.63K | SELL-OPTIONS | 0.00% | 180.90K | Mar 15 | View |
| Mar 16, 2012 | James S Evans | CHIEF FINANCIAL OFFICER | 0.00 | $16.84 | -$75.10K | SELL-OPTIONS | 0.00% | 45.60K | Mar 15 | View |
| Mar 16, 2012 | Jerry S Lanchbury | CHIEF SCIENTIFIC OFFICER | 0.00 | $17.02 | -$478.90K | SELL-OPTIONS | 0.00% | 22.73K | Mar 15 - Mar 16 | View |
| Mar 16, 2012 | Robert Gardner Harrison | CHIEF INFORMATION OFFICER | 0.00 | $16.62 | -$602.34K | SELL-OPTIONS | 0.00% | 5.89K | Mar 15 | View |
| Mar 08, 2012 | Peter D Meldrum | PRESIDENT & C.E.O. | 0.00 | $15.57 | -$309.43K | SELL-OPTIONS | 0.00% | 180.90K | Mar 08 | View |
| Feb 28, 2012 | Richard M Marsh | E.V.P., GENERAL COUNSEL | 0.00 | $15.11 | -$942.30K | SELL-OPTIONS | 0.00% | 14.01K | Feb 27 | View |
| Feb 17, 2012 | Peter D Meldrum | PRESIDENT & C.E.O. | -20.00 | $16.90 | -$416.93K | SELL | -0.01% | 180.90K | Feb 16 - Feb 17 | View |
| Feb 17, 2012 | Robert Gardner Harrison | CHIEF INFORMATION OFFICER | 0.00 | $18.02 | -$23.72K | SELL-OPTIONS | 0.00% | 5.89K | Feb 15 | View |
| Feb 09, 2012 | Peter D Meldrum | PRESIDENT & C.E.O. | 0.00 | $18.32 | -$73.84K | SELL-OPTIONS | 0.00% | 180.92K | Feb 07 | View |
| Feb 09, 2012 | Richard Marsh | E.V.P., GENERAL COUNSEL | -7.67K | $14.96 | -$269.30K | SELL | -100.00% | 0.00 | Dec 02 - Feb 07 | View |
| Feb 07, 2012 | Peter D Meldrum | PRESIDENT & C.E.O. | 0.00 | $18.30 | -$602.84K | SELL-OPTIONS | 0.00% | 180.92K | Feb 03 - Feb 06 | View |
| Feb 07, 2012 | Jim Evans | CHIEF FINANCIAL OFFICER | 0.00 | $18.31 | -$99.80K | SELL-OPTIONS | 0.00% | 45.60K | Feb 03 - Feb 06 | View |
| Feb 02, 2012 | Peter D Meldrum | PRESIDENT & C.E.O. | 0.00 | $13.87 | -$608.47K | SELL-OPTIONS | 0.00% | 180.92K | Jan 31 - Feb 01 | View |
| Feb 02, 2012 | Jerry S Lanchbury | CHIEF SCIENTIFIC OFFICER | -6.47K | $16.35 | -$481.09K | SELL | -22.14% | 22.73K | Dec 09 - Feb 01 | View |
| Jan 27, 2012 | Peter D Meldrum | PRESIDENT & C.E.O. | 0.00 | $13.42 | -$288.64K | SELL-OPTIONS | 0.00% | 180.92K | Jan 25 - Jan 26 | View |
| Jun 16, 2011 | Peter Meldrum | PRESIDENT & C.E.O. | 0.00 | $22.11 | -$74.96K | SELL-OPTIONS | 0.00% | 175.09K | Jun 15 | View |
| May 26, 2011 | Peter Meldrum | PRESIDENT & C.E.O. | 0.00 | $22.62 | -$95.20K | SELL-OPTIONS | 0.00% | 173.93K | May 25 | View |
| May 19, 2011 | Peter D Meldrum | PRESIDENT & C.E.O. | 0.00 | $22.45 | -$88.59K | SELL-OPTIONS | 0.00% | 173.93K | May 18 | View |
| May 19, 2011 | Jim Evans | CHIEF FINANCIAL OFFICER | 0.00 | $24.09 | -$5.60K | SELL-OPTIONS | 0.00% | 44.41K | May 18 | View |
| May 19, 2011 | Jerry S Lanchbury | CHIEF SCIENTIFIC OFFICER | 0.00 | $15.97 | -$800.79K | SELL-OPTIONS | 0.00% | 24.20K | May 18 | View |
| May 16, 2011 | James Evans | CHIEF FINANCIAL OFFICER | 0.00 | $24.02 | -$4.85K | SELL-OPTIONS | 0.00% | 44.41K | May 12 | View |
| May 12, 2011 | Richard M Marsh | E.V.P., GENERAL COUNSEL | -7.44K | $14.59 | -$1.19M | SELL | -26.36% | 20.80K | May 04 - May 10 | View |
| May 12, 2011 | Robert G. Harrison | CHIEF INFORMATION OFFICER | 0.00 | $22.34 | -$29.63K | SELL-OPTIONS | 0.00% | 4.67K | May 09 - May 11 | View |
| May 04, 2011 | Jerry Lanchbury | CHIEF SCIENTIFIC OFFICER | -5.30K | $22.75 | -$120.58K | SELL | -17.97% | 24.20K | May 04 | View |
| May 02, 2011 | Jerry Lanchbury | CHIEF SCIENTIFIC OFFICER | -4.70K | $22.00 | -$103.42K | SELL | -13.74% | 29.50K | Apr 29 | View |
| Dec 01, 2010 | Lawrence C Best | DIRECTOR | -90.00K | $21.54 | -$1.94M | SELL | -47.37% | 100.00K | Nov 30 - Dec 01 | View |
| Mar 12, 2010 | James S Evans | CHIEF FINANCIAL OFFICER | 0.00 | $16.41 | -$126.76K | SELL-OPTIONS | 0.00% | 34.29K | Mar 11 - Mar 12 | View |
| Mar 08, 2010 | Peter D Meldrum | PRESIDENT & C.E.O. | 0.00 | $15.58 | -$413.38K | SELL-OPTIONS | 0.00% | 201.83K | Mar 08 | View |
| Mar 05, 2010 | Peter D Meldrum | PRESIDENT & C.E.O. | 0.00 | $15.92 | -$653.82K | SELL-OPTIONS | 0.00% | 201.83K | Mar 04 - Mar 05 | View |
| Jan 08, 2010 | Linda S Wilson | DIRECTOR | -2.50K | $18.61 | -$531.53K | SELL | -50.00% | 2.50K | Jan 07 | View |
| Dec 23, 2009 | Jerry S Lanchbury | EXECUTIVE V.P. - RESEARCH | -26.43K | $26.01 | -$687.42K | SELL | -56.92% | 20.00K | Dec 23 | View |
| Nov 06, 2009 | Mark H Skolnick | CHIEF SCIENTIFIC OFFICER | -235.22K | $20.91 | -$3.82M | SELL | -87.37% | 34.00K | Oct 28 - Nov 05 | View |
| Sep 10, 2009 | Robert Gardner Harrison | CHIEF INFORMATION OFFICER | 0.00 | $20.88 | -$269.86K | SELL-OPTIONS | 0.00% | 2.54K | Sep 10 | View |
| Aug 31, 2009 | Gregory C Critchfield | PRESIDENT MYRIAD GENETIC LABS | 0.00 | $19.80 | -$1.02M | SELL-OPTIONS | 0.00% | 129.55K | Aug 28 | View |
| May 29, 2009 | Adrian N Hobden | PRES. MYRIAD PHARMACEUTICALS | 0.00 | $18.20 | -$1.26M | SELL-OPTIONS | 0.00% | 195.73K | May 27 | View |
| May 14, 2009 | John T Henderson | DIRECTOR | 300.00 | $32.73 | $9.82K | BUY | 7.50% | 4.30K | May 13 | View |
| May 11, 2009 | Mark H Skolnick | CHIEF SCIENTIFIC OFFICER | -24.70K | $17.38 | -$659.08K | SELL | -8.63% | 261.54K | Mar 02 - May 11 | View |
| May 07, 2009 | Gerald P Belle | DIRECTOR | 1.00K | $32.50 | $32.50K | BUY | 500.00% | 1.20K | May 07 | View |
| Apr 07, 2009 | Mark C. Capone | CHIEF OPERATING OFFICER, MGL | 0.00 | $30.63 | -$895.52K | SELL-OPTIONS | 0.00% | 20.45K | Apr 06 | View |
| Mar 27, 2009 | Jerry S Lanchbury | EXECUTIVE V.P. - RESEARCH | 0.00 | $27.61 | -$765.10K | SELL-OPTIONS | 0.00% | 41.43K | Mar 26 | View |
| Mar 27, 2009 | W. Wayne Laslie | CHIEF OPERATING OFFICER, MPI | 0.00 | $27.36 | -$845.04K | SELL-OPTIONS | 0.00% | 15.08K | Mar 27 | View |
| Mar 04, 2009 | Mark H Skolnick | CHIEF SCIENTIFIC OFFICER | 0.00 | $41.89 | -$148.44K | SELL-OPTIONS | 0.00% | 302.55K | Mar 04 | View |
| Mar 02, 2009 | Mark H Skolnick | CHIEF SCIENTIFIC OFFICER | 0.00 | $42.57 | -$680.21K | SELL-OPTIONS | 0.00% | 302.55K | Feb 27 | View |
| Feb 11, 2009 | Mark C. Capone | CHIEF OPERATING OFFICER, MGL | -6.08K | $57.38 | -$1.41M | SELL | -66.96% | 3.00K | Feb 09 | View |
| Feb 06, 2009 | Jerry S Lanchbury | EXECUTIVE V.P. - RESEARCH | 0.00 | $52.99 | -$626.42K | SELL-OPTIONS | 0.00% | 18.21K | Feb 06 | View |
| Feb 05, 2009 | Adrian N Hobden | PRES. MYRIAD PHARMACEUTICALS | 0.00 | $44.19 | -$1.89M | SELL-OPTIONS | 0.00% | 88.99K | Feb 05 | View |
| Feb 05, 2009 | Gregory C Critchfield | PRESIDENT MYRIAD GENETIC LABS | 0.00 | $50.57 | -$1.36M | SELL-OPTIONS | 0.00% | 62.51K | Feb 03 | View |
| Feb 05, 2009 | Peter D Meldrum | PRESIDENT & C.E.O. | -10.00K | $54.08 | -$1.70M | SELL | -8.73% | 104.60K | Feb 03 - Feb 05 | View |
| Feb 05, 2009 | Jerry S Lanchbury | EXECUTIVE V.P. - RESEARCH | 0.00 | $49.32 | -$653.60K | SELL-OPTIONS | 0.00% | 18.21K | Feb 03 | View |
| Feb 05, 2009 | James S Evans | CHIEF FINANCIAL OFFICER | 0.00 | $48.49 | -$691.12K | SELL-OPTIONS | 0.00% | 8.42K | Feb 03 | View |
| Feb 05, 2009 | John T Henderson | DIRECTOR | 0.00 | $49.84 | -$652.28K | SELL-OPTIONS | 0.00% | 2.00K | Feb 05 | View |
| Feb 05, 2009 | Dennis Langer | DIRECTOR | 0.00 | $54.93 | -$833.48K | SELL-OPTIONS | 0.00% | 0.00 | Feb 05 | View |
| Feb 05, 2009 | Robert Gardner Harrison | CHIEF INFORMATION OFFICER | 0.00 | $48.51 | -$271.89K | SELL-OPTIONS | 0.00% | 810.00 | Feb 03 | View |
| Feb 04, 2009 | Richard M Marsh | V.P., GENERAL COUNSEL | 4.86K | $51.84 | -$638.56K | SELL-OPTIONS | 50.27% | 14.54K | Feb 02 - Feb 04 | View |
| Jan 30, 2009 | Richard M Marsh | V.P., GENERAL COUNSEL | -1.60K | $46.45 | -$663.48K | SELL | -28.57% | 4.00K | Nov 05 - Jan 30 | View |
| Jan 30, 2009 | Gregory C Critchfield | PRESIDENT MYRIAD GENETIC LABS | 9.38K | $43.13 | -$1.09M | SELL-OPTIONS | 17.67% | 62.51K | Dec 23 - Jan 29 | View |
| Dec 18, 2008 | Jerry S Lanchbury | EXECUTIVE V.P. - RESEARCH | 0.00 | $42.88 | -$482.35K | SELL-OPTIONS | 0.00% | 13.21K | Dec 18 | View |
| Dec 11, 2008 | Adrian N Hobden | PRES. MYRIAD PHARMACEUTICALS | 0.00 | $32.69 | -$1.12M | SELL-OPTIONS | 0.00% | 88.99K | Dec 11 | View |
| Dec 10, 2008 | Linda S Wilson | DIRECTOR | 0.00 | $49.24 | -$469.50K | SELL-OPTIONS | 0.00% | 2.50K | Dec 09 | View |
| Nov 12, 2008 | Mark H Skolnick | CHIEF SCIENTIFIC OFFICER | -17.25K | $37.97 | -$663.69K | SELL | -15.16% | 96.53K | Oct 17 - Nov 10 | View |
| Nov 06, 2008 | W. Wayne Laslie | CHIEF OPERATING OFFICER, MPI | 0.00 | $44.75 | -$606.00K | SELL-OPTIONS | 0.00% | 2.41K | Nov 04 | View |
| Nov 06, 2008 | Peter D Meldrum | PRESIDENT & C.E.O. | -23.00K | $70.37 | -$703.72K | SELL | -16.72% | 114.60K | Nov 04 | View |
| Sep 29, 2008 | James S Evans | CHIEF FINANCIAL OFFICER | -6.67K | $69.00 | -$460.16K | SELL | -44.20% | 8.42K | Sep 25 | View |
| Sep 25, 2008 | Adrian N Hobden | PRES. MYRIAD PHARMACEUTICALS | -5.00K | $36.83 | -$976.89K | SELL | -6.86% | 67.92K | Sep 23 - Sep 25 | View |
| Sep 23, 2008 | Adrian N Hobden | PRES. MYRIAD PHARMACEUTICALS | 0.00 | $35.56 | -$60.39K | SELL-OPTIONS | 0.00% | 72.92K | Sep 19 | View |
| Sep 19, 2008 | Linda S Wilson | DIRECTOR | 0.00 | $46.91 | -$472.30K | SELL-OPTIONS | 0.00% | 2.50K | Sep 19 | View |
| Sep 19, 2008 | Adrian N Hobden | PRES. MYRIAD PHARMACEUTICALS | 10.00K | $35.81 | $20.57K | SELL-OPTIONS | 15.89% | 72.92K | Sep 17 - Sep 18 | View |
| Sep 17, 2008 | Gregory C Critchfield | PRESIDENT MYRIAD GENETIC LABS | 0.00 | $39.31 | -$1.73M | SELL-OPTIONS | 0.00% | 53.12K | Sep 17 | View |
| Sep 17, 2008 | Mark H Skolnick | CHIEF SCIENTIFIC OFFICER | -19.50K | $66.00 | -$1.29M | SELL | -13.83% | 121.53K | Sep 16 | View |
| Sep 08, 2008 | William A. Hockett | V. P. CORP COMMUNICATIONS | 0.00 | $46.84 | -$978.12K | SELL-OPTIONS | 0.00% | 9.00K | Sep 08 | View |
| Sep 08, 2008 | Walter Gilbert | DIRECTOR | 0.00 | $44.52 | -$375.75K | SELL-OPTIONS | 0.00% | 0.00 | Sep 05 | View |
| Sep 08, 2008 | Dennis Langer | DIRECTOR | 0.00 | $43.13 | -$432.85K | SELL-OPTIONS | 0.00% | 0.00 | Sep 04 - Sep 05 | View |
| Sep 05, 2008 | Mark H Skolnick | CHIEF SCIENTIFIC OFFICER | -7.40K | $68.51 | -$34.26K | SELL | -5.53% | 126.53K | Sep 03 | View |
| Sep 05, 2008 | Jerry S Lanchbury | EXECUTIVE V.P. - RESEARCH | 6.71K | $41.84 | -$897.75K | SELL-OPTIONS | 103.29% | 13.21K | Sep 03 - Sep 04 | View |
| Sep 03, 2008 | Peter D Meldrum | PRESIDENT & C.E.O. | 9.73K | $39.41 | -$812.44K | SELL-OPTIONS | 7.61% | 137.60K | Aug 29 - Sep 02 | View |
| Sep 03, 2008 | Richard M Marsh | V.P., GENERAL COUNSEL | 0.00 | $43.06 | -$564.36K | SELL-OPTIONS | 0.00% | 11.27K | Aug 29 | View |
| Sep 03, 2008 | Mark C. Capone | CHIEF OPERATING OFFICER, MGL | 0.00 | $43.46 | -$881.20K | SELL-OPTIONS | 0.00% | 6.08K | Aug 29 | View |
| Aug 27, 2008 | Adrian N Hobden | PRES. MYRIAD PHARMACEUTICALS | 0.00 | $35.08 | -$1.65M | SELL-OPTIONS | 0.00% | 62.92K | Aug 25 | View |
| Aug 27, 2008 | Robert Gardner Harrison | CHIEF INFORMATION OFFICER | 0.00 | $39.26 | -$217.69K | SELL-OPTIONS | 0.00% | 810.00 | Aug 27 | View |
| Mar 20, 2008 | Mark H Skolnick | CHIEF SCIENTIFIC OFFICER | 0.00 | $22.11 | -$51.18K | SELL-OPTIONS | 0.00% | 290.56K | Mar 20 | View |
| Mar 20, 2008 | Mark H Skolnick | CHIEF SCIENTIFIC OFFICER | 0.00 | $22.15 | -$322.64K | SELL-OPTIONS | 0.00% | 252.56K | Mar 20 | View |
| Mar 20, 2008 | Mark H Skolnick | CHIEF SCIENTIFIC OFFICER | 0.00 | $22.27 | -$140.78K | SELL-OPTIONS | 0.00% | 252.56K | Mar 20 | View |
| Feb 07, 2008 | Mark H Skolnick | CHIEF SCIENTIFIC OFFICER | 0.00 | $24.03 | -$23.55K | SELL-OPTIONS | 0.00% | 300.56K | Feb 07 | View |
| Feb 07, 2008 | Mark H Skolnick | CHIEF SCIENTIFIC OFFICER | 0.00 | $24.11 | -$606.89K | SELL-OPTIONS | 0.00% | 262.56K | Feb 07 | View |
| Feb 07, 2008 | Mark H Skolnick | CHIEF SCIENTIFIC OFFICER | 0.00 | $24.42 | -$111.83K | SELL-OPTIONS | 0.00% | 262.56K | Feb 07 | View |
| Jan 04, 2008 | William A. Hockett III | V. P. CORP COMMUNICATIONS | -1.69K | $50.43 | -$85.32K | SELL | -59.10% | 1.17K | Dec 07 | View |
| Dec 21, 2007 | Dennis Langer | DIRECTOR | 0.00 | $32.97 | -$876.04K | SELL-OPTIONS | 0.00% | 0.00 | Dec 19 - Dec 20 | View |
| Dec 19, 2007 | William A. Hockett III | V. P. CORP COMMUNICATIONS | -1.00K | $51.00 | -$51.00K | SELL | -37.61% | 1.66K | Dec 07 | View |
| Dec 10, 2007 | Mark H Skolnick | CHIEF SCIENTIFIC OFFICER | -27.00K | $50.44 | -$1.36M | SELL | -16.51% | 136.53K | Dec 06 | View |
| Dec 05, 2007 | W. Wayne Laslie | CHIEF OPERATING OFFICER, MPI | -1.12K | $48.30 | -$54.19K | SELL | -34.74% | 2.11K | Dec 04 | View |
| Dec 04, 2007 | Linda S Wilson | DIRECTOR | -1.10K | $29.50 | -$945.29K | SELL | -30.56% | 2.50K | Nov 30 | View |
| Nov 06, 2007 | Walter Gilbert | DIRECTOR | 0.00 | $35.42 | -$176.89K | SELL-OPTIONS | 0.00% | 0.00 | Nov 05 | View |
| Nov 06, 2007 | Walter Gilbert | DIRECTOR | 0.00 | $36.10 | -$1.01M | SELL-OPTIONS | 0.00% | 0.00 | Nov 05 | View |
| Oct 16, 2007 | William A. Hockett III | V. P. CORP COMMUNICATIONS | -84.00 | $55.67 | -$4.68K | SELL | -3.27% | 2.49K | Oct 15 | View |
| Oct 16, 2007 | William A. Hockett III | V. P. CORP COMMUNICATIONS | -1.73K | $55.33 | -$95.61K | SELL | -40.19% | 2.57K | Oct 15 | View |
| Oct 16, 2007 | William A. Hockett III | V. P. CORP COMMUNICATIONS | -3.07K | $54.91 | -$168.79K | SELL | -41.69% | 4.30K | Oct 15 | View |
| Oct 16, 2007 | James S Evans | V.P. FINANCE | -6.55K | $54.98 | -$360.37K | SELL | -43.97% | 8.35K | Oct 15 | View |
| Oct 16, 2007 | Peter D Meldrum | PRESIDENT & C.E.O. | -20.00K | $55.31 | -$1.11M | SELL | -13.32% | 130.16K | Oct 15 | View |
| Oct 16, 2007 | Jay M Moyes | CHIEF FINANCIAL OFFICER | 0.00 | $33.83 | -$427.27K | SELL-OPTIONS | 0.00% | 25.48K | Oct 15 | View |
| Oct 16, 2007 | Jay M Moyes | CHIEF FINANCIAL OFFICER | 0.00 | $34.02 | -$200.93K | SELL-OPTIONS | 0.00% | 25.28K | Oct 15 | View |
| Oct 16, 2007 | Jay M Moyes | CHIEF FINANCIAL OFFICER | 0.00 | $33.87 | -$253.00K | SELL-OPTIONS | 0.00% | 25.28K | Oct 15 | View |
| Oct 16, 2007 | Jay M Moyes | CHIEF FINANCIAL OFFICER | 0.00 | $33.79 | -$419.40K | SELL-OPTIONS | 0.00% | 25.28K | Oct 15 | View |
| Oct 16, 2007 | Jay M Moyes | CHIEF FINANCIAL OFFICER | 0.00 | $33.65 | -$380.34K | SELL-OPTIONS | 0.00% | 25.28K | Oct 15 | View |
| Oct 15, 2007 | W. Wayne Laslie | CHIEF OPERATING OFFICER, MPI | 0.00 | $38.38 | -$377.63K | SELL-OPTIONS | 0.00% | 3.07K | Oct 11 | View |
| Oct 09, 2007 | Jerry S Lanchbury | EXECUTIVE V.P. - RESEARCH | 0.00 | $46.34 | -$658.98K | SELL-OPTIONS | 0.00% | 0.00 | Oct 05 | View |
| Sep 28, 2007 | Jerry S Lanchbury | EXECUTIVE V.P. - RESEARCH | 0.00 | $33.41 | -$373.24K | SELL-OPTIONS | 0.00% | 0.00 | Sep 27 | View |
| Sep 27, 2007 | Gregory C Critchfield | PRESIDENT MYRIAD GENETIC LABS | 0.00 | $27.39 | -$1.27M | SELL-OPTIONS | 0.00% | 45.81K | Sep 25 - Sep 26 | View |
| Sep 27, 2007 | Adrian N Hobden | PRES. MYRIAD PHARMACEUTICALS | 0.00 | $27.56 | -$897.50K | SELL-OPTIONS | 0.00% | 47.24K | Sep 25 | View |
| Sep 27, 2007 | Richard M Marsh | V.P., GENERAL COUNSEL | 0.00 | $31.27 | -$468.25K | SELL-OPTIONS | 0.00% | 2.04K | Sep 25 - Sep 26 | View |
| Sep 14, 2007 | Jay M Moyes | CHIEF FINANCIAL OFFICER | 0.00 | $28.98 | -$17.18K | SELL-OPTIONS | 0.00% | 25.48K | Sep 13 | View |
| Sep 14, 2007 | Jay M Moyes | CHIEF FINANCIAL OFFICER | 0.00 | $27.08 | -$585.49K | SELL-OPTIONS | 0.00% | 25.28K | Sep 13 | View |
| Sep 14, 2007 | Jay M Moyes | CHIEF FINANCIAL OFFICER | 0.00 | $27.17 | -$493.05K | SELL-OPTIONS | 0.00% | 25.28K | Sep 13 | View |
| Sep 14, 2007 | Jay M Moyes | CHIEF FINANCIAL OFFICER | 0.00 | $28.69 | -$1.04M | SELL-OPTIONS | 0.00% | 25.28K | Sep 13 | View |
| Sep 14, 2007 | Jay M Moyes | CHIEF FINANCIAL OFFICER | 0.00 | $27.09 | -$1.00M | SELL-OPTIONS | 0.00% | 25.28K | Sep 12 - Sep 13 | View |
| Sep 14, 2007 | Peter D Meldrum | PRESIDENT & C.E.O. | 0.00 | $28.25 | -$378.70K | SELL-OPTIONS | 0.00% | 150.16K | Sep 12 | View |
| Sep 14, 2007 | James S Evans | V.P. FINANCE | -3.91K | $47.19 | -$184.72K | SELL | -20.79% | 14.91K | Sep 13 | View |
| Sep 14, 2007 | Peter D Meldrum | PRESIDENT & C.E.O. | 0.00 | $28.17 | -$424.86K | SELL-OPTIONS | 0.00% | 150.16K | Sep 14 | View |
| Aug 09, 2007 | W. Wayne Laslie | CHIEF OPERATING OFFICER, MPI | 0.00 | $29.88 | -$186.75K | SELL-OPTIONS | 0.00% | 3.07K | Aug 07 | View |
| Aug 09, 2007 | Jerry S Lanchbury | EXECUTIVE V.P. - RESEARCH | 0.00 | $29.42 | -$730.67K | SELL-OPTIONS | 0.00% | 0.00 | Aug 07 - Aug 09 | View |
| Aug 09, 2007 | Mark C. Capone | CHIEF OPERATING OFFICER, MGL | 0.00 | $29.14 | -$132.34K | SELL-OPTIONS | 0.00% | 6.08K | Aug 07 | View |
| Aug 06, 2007 | Richard M Marsh | V.P., GENERAL COUNSEL | -579.00 | $40.00 | -$23.16K | SELL | -22.12% | 2.04K | Aug 06 | View |
| Jul 18, 2007 | Richard M Marsh | V.P., GENERAL COUNSEL | -5.58K | $40.00 | -$223.24K | SELL | -68.07% | 2.62K | Jul 16 | View |
| Jun 18, 2007 | Richard M Marsh | V.P., GENERAL COUNSEL | -6.00K | $37.78 | -$226.67K | SELL | -42.26% | 8.20K | Jun 18 | View |
| Jun 18, 2007 | Jay M Moyes | CHIEF FINANCIAL OFFICER | -1.50K | $37.73 | -$56.59K | SELL | -5.56% | 25.48K | Jun 15 | View |
| Jun 01, 2007 | Mark H Skolnick | CHIEF SCIENTIFIC OFFICER | 0.00 | $25.92 | -$741.75K | SELL-OPTIONS | 0.00% | 348.52K | May 31 | View |
| May 23, 2007 | Adrian N Hobden | PRES. MYRIAD PHARMACEUTICALS | 0.00 | $22.56 | -$348.75K | SELL-OPTIONS | 0.00% | 46.78K | May 23 | View |
| May 09, 2007 | Walter Gilbert | DIRECTOR | 0.00 | $24.38 | -$820.50K | SELL-OPTIONS | 0.00% | 0.00 | May 09 | View |
| May 08, 2007 | Mark H Skolnick | CHIEF SCIENTIFIC OFFICER | 0.00 | $25.81 | -$734.90K | SELL-OPTIONS | 0.00% | 348.52K | May 08 | View |
| May 08, 2007 | Peter D Meldrum | PRESIDENT & C.E.O. | -28.68K | $39.38 | -$787.68K | SELL | -14.91% | 163.64K | May 04 | View |
| May 04, 2007 | Arthur Hayes Jr. | DIRECTOR | 0.00 | $26.36 | -$400.71K | SELL-OPTIONS | 0.00% | 0.00 | May 03 | View |
| May 04, 2007 | William A. Hockett III | V. P. CORP COMMUNICATIONS | 0.00 | $28.57 | -$1.88M | SELL-OPTIONS | 0.00% | 7.37K | May 03 | View |
| May 03, 2007 | Peter D Meldrum | PRESIDENT & C.E.O. | -10.55K | $38.00 | -$380.00K | SELL | -5.20% | 192.31K | Apr 27 - May 02 | View |
| May 01, 2007 | Richard M Marsh | V.P., GENERAL COUNSEL | -3.99K | $37.50 | -$149.66K | SELL | -22.85% | 13.48K | May 01 | View |
| May 01, 2007 | Jerry S Lanchbury | EXECUTIVE V.P. - RESEARCH | 0.00 | $24.77 | -$214.03K | SELL-OPTIONS | 0.00% | 0.00 | May 01 | View |
| Apr 16, 2007 | Richard M Marsh | V.P., GENERAL COUNSEL | -5.00K | $36.08 | -$180.39K | SELL | -22.25% | 17.47K | Apr 16 | View |
| Mar 15, 2007 | William A. Hockett III | V. P. CORP COMMUNICATIONS | 0.00 | $22.10 | -$373.81K | SELL-OPTIONS | 0.00% | 7.37K | Mar 13 | View |
| Mar 14, 2007 | Mark H Skolnick | CHIEF SCIENTIFIC OFFICER | -5.00K | $33.81 | -$169.05K | SELL | -1.41% | 348.72K | Mar 12 | View |
| Feb 08, 2007 | James S Evans | VICE PRESIDENT FINANCE | 0.00 | $21.06 | -$179.33K | SELL-OPTIONS | 0.00% | 18.40K | Feb 06 | View |
| Jan 16, 2007 | S. George Simon | V.P. BUSINESS DEVELOPMENT | 0.00 | $23.46 | -$115.47K | SELL-OPTIONS | 0.00% | 2.28K | Jan 12 | View |
| Jan 16, 2007 | S. George Simon | V.P. BUSINESS DEVELOPMENT | 0.00 | $23.81 | -$112.74K | SELL-OPTIONS | 0.00% | 2.28K | Jan 16 | View |
| Jan 16, 2007 | Peter D Meldrum | PRESIDENT & C.E.O. | -10.00K | $35.00 | -$350.00K | SELL | -4.70% | 202.87K | Jan 12 | View |
| Jan 11, 2007 | Jerry S Lanchbury | EXECUTIVE V.P. - RESEARCH | 0.00 | $23.27 | -$107.30K | SELL-OPTIONS | 0.00% | 0.00 | Jan 11 | View |
| Jan 11, 2007 | Peter D Meldrum | PRESIDENT & C.E.O. | -10.00K | $33.00 | -$330.00K | SELL | -4.49% | 212.87K | Jan 10 | View |
| Jan 11, 2007 | Jay M Moyes | CHIEF FINANCIAL OFFICER | 0.00 | $23.03 | -$154.45K | SELL-OPTIONS | 0.00% | 26.52K | Jan 09 | View |
| Jan 03, 2007 | Adrian N Hobden | PRES. MYRIAD PHARMACEUTICALS | 0.00 | $18.56 | -$134.38K | SELL-OPTIONS | 0.00% | 46.78K | Jan 03 | View |
| Jan 03, 2007 | William A. Hockett III | V. P. CORP COMMUNICATIONS | 0.00 | $18.39 | -$136.09K | SELL-OPTIONS | 0.00% | 7.37K | Jan 03 | View |
| Dec 14, 2006 | Peter D Meldrum | PRESIDENT & C.E.O. | -29.29K | $30.90 | -$618.00K | SELL | -11.61% | 222.87K | Nov 07 - Dec 13 | View |
| Nov 20, 2006 | Jay M Moyes | CHIEF FINANCIAL OFFICER | 0.00 | $21.78 | -$134.07K | SELL-OPTIONS | 0.00% | 26.08K | Nov 16 - Nov 20 | View |
| Nov 15, 2006 | Jerry S Lanchbury | EXECUTIVE V.P. - RESEARCH | 0.00 | $20.77 | -$68.74K | SELL-OPTIONS | 0.00% | 0.00 | Nov 15 | View |
| Nov 13, 2006 | Walter Gilbert | DIRECTOR | -35.94K | $26.99 | -$969.88K | SELL | -100.00% | 0.00 | Nov 09 - Nov 10 | View |
| Nov 08, 2006 | Jerry Lanchbury | EXECUTIVE V.P. - RESEARCH | 0.00 | $20.77 | -$13.56K | SELL-OPTIONS | 0.00% | 0.00 | Nov 07 | View |
| Oct 19, 2006 | William A. Hockett III | V. P. CORP COMMUNICATIONS | 0.00 | $16.46 | -$198.17K | SELL-OPTIONS | 0.00% | 7.14K | Oct 19 | View |
| Oct 18, 2006 | Jay M Moyes | CHIEF FINANCIAL OFFICER | -5.00K | $27.08 | -$135.40K | SELL | -16.09% | 26.08K | Oct 18 | View |
| Aug 31, 2006 | Arthur H. Hayes Jr. M.D. | DIRECTOR | 0.00 | $19.63 | -$165.06K | SELL-OPTIONS | 0.00% | 0.00 | Aug 30 | View |
| Jun 07, 2006 | Mark H Skolnick | CHIEF SCIENTIFIC OFFICER | 0.00 | $18.65 | -$338.98K | SELL-OPTIONS | 0.00% | 357.95K | Jun 07 | View |
| May 09, 2006 | Mark H Skolnick | CHIEF SCIENTIFIC OFFICER | 0.00 | $20.19 | -$334.95K | SELL-OPTIONS | 0.00% | 357.95K | May 08 | View |
| May 05, 2006 | Peter D Meldrum | PRESIDENT & C.E.O. | 0.00 | $20.78 | -$124.57K | SELL-OPTIONS | 0.00% | 265.21K | May 04 | View |
| May 05, 2006 | S. George Simon | V.P. BUSINESS DEVELOPMENT | 0.00 | $19.38 | -$172.76K | SELL-OPTIONS | 0.00% | 916.00 | May 05 | View |
| Apr 27, 2006 | Adrian N Hobden | PRES. MYRIAD PHARMACEUTICALS | 0.00 | $15.57 | -$104.43K | SELL-OPTIONS | 0.00% | 45.65K | Apr 27 | View |
| Apr 17, 2006 | Gregory C Critchfield | PRESIDENT MYRIAD GENETIC LABS | 0.00 | $15.79 | -$622.96K | SELL-OPTIONS | 0.00% | 43.72K | Apr 17 | View |
| Mar 13, 2006 | Richard M Marsh | V.P., GENERAL COUNSEL | 0.00 | $20.05 | -$150.12K | SELL-OPTIONS | 0.00% | 10.45K | Mar 13 | View |
| Mar 09, 2006 | Arthur H. Hayes Jr. | DIRECTOR | -10.00K | $15.71 | -$558.00K | SELL | -100.00% | 0.00 | Mar 08 | View |
| Mar 09, 2006 | Walter Gilbert | DIRECTOR | 0.00 | $18.71 | -$791.40K | SELL-OPTIONS | 0.00% | 35.94K | Mar 07 - Mar 09 | View |
| Feb 27, 2006 | Jay M Moyes | CHIEF FINANCIAL OFFICER | 0.00 | $18.79 | -$37.21K | SELL-OPTIONS | 0.00% | 14.66K | Feb 27 | View |
| Feb 14, 2006 | William A. Hockett III | V. P. CORP COMMUNICATIONS | 0.00 | $15.06 | -$71.31K | SELL-OPTIONS | 0.00% | 6.85K | Feb 10 | View |
| Feb 14, 2006 | Peter D Meldrum | PRESIDENT & C.E.O. | -10.00K | $25.00 | -$250.00K | SELL | -3.76% | 255.98K | Feb 13 | View |
| Feb 14, 2006 | Jay M Moyes | CHIEF FINANCIAL OFFICER | 0.00 | $18.70 | -$158.79K | SELL-OPTIONS | 0.00% | 14.66K | Feb 10 | View |
| Feb 14, 2006 | S. George Simon | V.P. BUSINESS DEVELOPMENT | 0.00 | $17.87 | -$71.30K | SELL-OPTIONS | 0.00% | 916.00 | Feb 10 | View |
| Dec 21, 2005 | Jay M Moyes | CHIEF FINANCIAL OFFICER | -2.45K | $19.98 | -$48.91K | SELL | -14.31% | 14.66K | Dec 21 | View |
| Jan 14, 2005 | S. George Simon | V.P. BUSINESS DEVELOPMENT | 0.00 | $17.93 | -$28.76K | SELL-OPTIONS | 0.00% | 0.00 | Jan 13 | View |
| Jan 14, 2005 | Adrian N Hobden | PRES. MYRIAD PHARMACEUTICALS | 0.00 | $15.06 | -$40.23K | SELL-OPTIONS | 0.00% | 44.17K | Jan 13 | View |
| Nov 12, 2004 | S. George Simon | V.P. BUSINESS DEVELOPMENT | -653.00 | $20.00 | -$13.06K | SELL | -100.00% | 0.00 | Nov 12 | View |
| May 11, 2004 | John T Henderson | DIRECTOR | 2.00K | $17.03 | $34.06K | BUY | ∞ | 2.00K | May 11 | View |
| Feb 06, 2004 | Robert S Attiyeh | DIRECTOR | 2.00K | $16.65 | $33.30K | BUY | 200.00% | 3.00K | Feb 06 | View |
FAQ
Q
Is insider trading legal?
A
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
Q
What are some examples of market manipulation?
A
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
MYGN Insider Trading News
People Also Watch
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved